Breaking News

Metrics Expands Capabilities

April 19, 2013

Adds liquids, creams and gels for pharma applications

Metrics Inc. has added capabilities to produce non-sterile liquids, creams and gels for a broad range of pharmaceutical applications. Metrics can manage the formulation development of new products or the technology transfer of existing products for manufacturing and packaging, as well as provide any necessary lab support services.
The company’s cream suite can manufacture two- and three-phase suspensions and emulsions, including pastes, creams, lotions and gels. Its two modular filling lines and its liquid processing equipment can produce batch sizes ranging from 250 to 2,000 kilograms. The liquid suite can manufacture bulk liquids, including mouthwash, antiseptics, elixirs and suspensions. A flame-proofed area also is available for processing flammable liquids. The suite’s four liquid manufacturing vessels produce batch sizes ranging from 350 to 6,000 liters.
“The addition of liquids, creams and gels to Metrics’ portfolio of capabilities is just the latest chapter in what has been our tale from the start – delivering demonstrated scientific and operational excellence in response to our clients’ growing and changing needs,” said Phil Hodges, president. “It is an honor to serve our clients in this new way and, hopefully, continue to build upon our long-time relationships based on mutual trust and respect.”

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?